Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
37 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Verastem, Inc. (Verastem) is a biopharmaceutical company that discovers and develops drugs to treat cancer by the targeted killing of cancer stem cells. The companys products include VS-6063, VS-4718 and VS-5584. Its VS-6063 is used for the treatment of lung cancer, mesothelioma, and ovarian cancer. Verastems VS-4718 and VS-5584 is used for the treatment of solid tumors and lymphomas. The company developed proprietary technology to create a stable population of CSCs that are suitable for use in high-throughput screening of small molecule compounds. It develops drugs that solve the problem of cancer recurrence and metastasis. Verastem is headquartered in Needham, Massachusetts, the US

Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shape

  
Source:
Document ID
GDPH289833D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Verastem, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Verastem, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Verastem, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Verastem, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Verastem, Inc., Medical Devices Deals, 2010 to YTD 201691
Verastem, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Verastem, Inc., Pharmaceuticals &Healthcare, Deal Details1123
  Venture Financing111
    Verastem Secures US$20.1 Million In Series B-2 Financing111
    Verastem Secures US$32 Million In Series B Financing122
    Verastem Secures US$16 Million In Series A Round Of Financing142
  Partnerships161
    Merck, Pfizer and Verastem Enter into Agreement161
    Verastem Enters Into Research Agreement With Eisai For Small Molecule Wnt Inhibitors171
  Licensing Agreements181
    Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718182
    Verastem Enters Into Licensing Agreement With Pfizer For VS-6063202
    Verastem Enters into Licensing Agreement with Poniard Pharma221
    Verastem Enters into Licensing Agreement with Whitehead Institute for Biomedical Research231
    Verastem Enters into Licensing Agreement with Whitehead Institute for Biomedical Research to Treat Cancer242
  Equity Offering261
    Verastem USD54 Million in Public Offering of Shares262
    Verastem Files Registration Statement For Public Offering Of Common Stock For US$35 Million282
    Verastem Completes Public Offering Of Shares For US$63.8 Million302
    Verastem Completes IPO For US$63 Million322
Verastem, Inc. - Key Competitors341
Key Employees351
Locations And Subsidiaries361
  Head Office361
  Other Locations &Subsidiaries361
Appendix371
  Methodology371
  About GlobalData371
  Contact Us371
  Disclaimer371

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Verastem-Inc-VSTM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6685>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Verastem-Inc-VSTM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6685>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research